Kynam Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9M | Sell |
4,427,927
-272,073
| -6% | -$3.8M | 6.66% | 7 |
|
|
2025
Q1 | $63.4M | Buy |
4,700,000
+1,373,738
| +41% | +$18.5M | 5.32% | 7 |
|
|
2024
Q4 | $63.8M | Buy |
3,326,262
+814,967
| +32% | +$15.6M | 3.77% | 9 |
|
|
2024
Q3 | $57.1M | Buy |
2,511,295
+761,295
| +44% | +$17.3M | 4.38% | 10 |
|
|
2024
Q2 | $22.8M | Buy |
1,750,000
+1,616,123
| +1,207% | +$21M | 1.76% | 11 |
|
|
2024
Q1 | $2.34M | Sell |
133,877
-474,038
| -78% | -$8.3M | 0.25% | 21 |
|
|
2023
Q4 | $13.2M | Sell |
607,915
-91,766
| -13% | -$2M | 1.47% | 16 |
|
|
2023
Q3 | $10.7M | Sell |
699,681
-9,817
| -1% | -$151K | 1.76% | 14 |
|
|
2023
Q2 | $16.9M | Buy |
709,498
+165,895
| +31% | +$3.95M | 2.32% | 12 |
|
|
2023
Q1 | $13.8M | Sell |
543,603
-491,094
| -47% | -$12.5M | 1.79% | 16 |
|
|
2022
Q4 | $30.2M | Buy |
1,034,697
+34,697
| +3% | +$1.01M | 4.64% | 6 |
|
|
2022
Q3 | $20.5M | Buy |
1,000,000
+409,857
| +69% | +$8.41M | 4.32% | 7 |
|
|
2022
Q2 | $6.83M | Buy |
590,143
+317
| +0.1% | +$3.67K | 1.74% | 14 |
|
|
2022
Q1 | $10.9M | Buy |
589,826
+301,892
| +105% | +$5.58M | 3.54% | 10 |
|
|
2021
Q4 | $5.69M | Buy |
+287,934
| New | +$5.69M | 3.04% | 11 |
|